Erratum

Código QR

Erratum

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	Karger Publishers 2021
Materias:	Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/6a4e1efb56bd44ee92f41dce1facaaca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Humoral immune response and lymphocyte levels after complete vaccination against COVID-19 in a cohort of multiple sclerosis patients treated with cladribine tablets
por: Christoph Grothe, et al.
Publicado: (2021)

Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
por: Hua-Ying Cai, et al.
Publicado: (2021)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Zachary D. Wallen, et al.
Publicado: (2021)

Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach
por: Carolina Gonzalez-Riano, et al.
Publicado: (2021)

Parkinson’s disease patients benefit from bicycling - a systematic review and meta-analysis
por: Marianne Tiihonen, et al.
Publicado: (2021)

Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes
por: Adithya Gopinath, et al.
Publicado: (2021)

Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort
por: Giulia Di Lazzaro, et al.
Publicado: (2021)

TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
por: Megan C. Bakeberg, et al.
Publicado: (2021)

Longitudinal evolution of non-motor symptoms in early Parkinson’s disease: a 3-year prospective cohort study
por: Ruwei Ou, et al.
Publicado: (2021)

A real-world study of wearable sensors in Parkinson’s disease
por: Jamie L. Adams, et al.
Publicado: (2021)

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Rubén Fernández-Santiago, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: J. M. Hatcher-Martin, et al.
Publicado: (2021)

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
por: Francesc Valldeoriola, et al.
Publicado: (2021)

Microdialysis and microperfusion electrodes in neurologic disease monitoring
por: Luke A. Stangler, et al.
Publicado: (2021)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Tainá M. Marques, et al.
Publicado: (2021)

A transcriptome-wide association study identifies susceptibility genes for Parkinson’s disease
por: Shi Yao, et al.
Publicado: (2021)

Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes
por: M. Lenard Lachenmayer, et al.
Publicado: (2021)

Lateralized effects of deep brain stimulation in Parkinson’s disease: evidence and controversies
por: Zhengyu Lin, et al.
Publicado: (2021)

A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson’s disease
por: Agnes Langer, et al.
Publicado: (2021)

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
por: Bruna Meira, et al.
Publicado: (2021)

Author Correction: Pallidal stimulation as treatment for camptocormia in Parkinson’s disease
por: Yijie Lai, et al.
Publicado: (2021)

Fiber-specific white matter alterations in early-stage tremor-dominant Parkinson’s disease
por: Christina Andica, et al.
Publicado: (2021)

Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
por: G. Carola, et al.
Publicado: (2021)

Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
por: Paula Ramos-Gonzalez, et al.
Publicado: (2021)

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
por: E. Giusto, et al.
Publicado: (2021)

Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features
por: Jonathan P. Bestwick, et al.
Publicado: (2021)

Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors
por: Anthony R. Braun, et al.
Publicado: (2021)

Decreased frontotemporal connectivity in patients with parkinson’s disease experiencing face pareidolia
por: Yuta Kajiyama, et al.
Publicado: (2021)

Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
por: Elke Warmerdam, et al.
Publicado: (2021)

Delayed orthostatic hypotension in Parkinson’s disease
por: Sang-Won Yoo, et al.
Publicado: (2021)

Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
por: Matthew Brendel, et al.
Publicado: (2021)

Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
por: Luca Baldelli, et al.
Publicado: (2021)

Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease
por: Ning-Ning Che, et al.
Publicado: (2021)

Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease
por: Tommaso Bocci, et al.
Publicado: (2021)

Toward asleep DBS: cortico-basal ganglia spectral and coherence activity during interleaved propofol/ketamine sedation mimics NREM/REM sleep activity
por: Jing Guang, et al.
Publicado: (2021)

Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis
por: Danny Bega, et al.
Publicado: (2021)

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Mary K. Herrick, et al.
Publicado: (2021)

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
por: Stefano Romano, et al.
Publicado: (2021)

Rheumatoid arthritis decreases risk for Parkinson’s disease: a Mendelian randomization study
por: ChunYu Li, et al.
Publicado: (2021)

How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review
por: Agnes Langer, et al.
Publicado: (2021)